# Relates to requiring homeless shelters to keep an opioid antagonist on hand, have at least one trained employee on duty at all times, and develop a training plan for opioid overdoses

**Bill ID:** S1872AA
**Session:** 2023
**Sponsor:** Cordell Cleare
**Status:** In Senate Committee
**PDF:** [S1872A PDF](https://legislation.nysenate.gov/pdf/bills/2023/S1872A)

## Summary

Requires homeless shelters to keep an opioid antagonist on hand at all times and trained personnel when required by when applicable law, regulation, code, or operating plan approved by a social services district or the commissioner otherwise requires employees to be at the premises, sets out the requirements for the training of those employees; develops a training plan for opioid overdoses in conjunction with a registered opioid overdose prevention program.

---

## Full Text

S T A T E  O F  N E W  Y O R K
 ________________________________________________________________________
 
  1872--A
 
  2023-2024 Regular Sessions
 
  I N  S E N A T E
 
  January 17, 2023
  ___________
 
 Introduced  by  Sens.  CLEARE, COMRIE, FERNANDEZ, WEIK -- read twice and
  ordered printed, and when printed to be committed to the Committee  on
  Social  Services -- recommitted to the Committee on Social Services in
  accordance with Senate Rule 6, sec. 8 --  committee  discharged,  bill
  amended,  ordered reprinted as amended and recommitted to said commit-
  tee
 
 AN ACT to amend the social services law, in relation to requiring  home-
  less  shelters to keep an opioid antagonist on hand, have at least one
  trained employee on duty at all times, and provide  an  opioid  antag-
  onist training program for residents
 
  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
  Section 1. Article 2-A of the social services law is amended by adding
 a new title 3 to read as follows:
  TITLE 3
  OPIOID ANTAGONISTS IN HOMELESS SHELTERS
 SECTION 47. OPIOID ANTAGONIST USE AND TRAINING.
  ยง 47. OPIOID ANTAGONIST USE AND TRAINING. 1. ANY PROVIDER OF TEMPORARY
 HOUSING ASSISTANCE, WHICH SHALL INCLUDE, BUT NOT BE LIMITED TO, A FAMILY
 SHELTER, A SHELTER FOR ADULTS, A HOTEL, AN EMERGENCY APARTMENT, A DOMES-
 TIC VIOLENCE SHELTER, A RUNAWAY AND HOMELESS YOUTH SHELTER,  OR  A  SAFE
 HOUSE FOR REFUGEES OPERATING IN THIS STATE SHALL HAVE AT ITS PREMISES:
  (A)  AN  OPIOID ANTAGONIST AND A METHOD OF ADMINISTERING IT ON SITE AT
 ALL TIMES WHICH MAY INCLUDE, BUT NOT BE LIMITED TO, A NALOXONE KIT; AND
  (B) AT A MINIMUM, ONE EMPLOYEE TRAINED IN  THE  ADMINISTRATION  OF  AN
 OPIOID  ANTAGONIST ON DUTY AT ALL TIMES WHEN APPLICABLE LAW, REGULATION,
 CODE, OR OPERATING PLAN APPROVED BY A SOCIAL SERVICES  DISTRICT  OR  THE
 COMMISSIONER OTHERWISE REQUIRES EMPLOYEES TO BE AT THE PREMISES.
  2.  ALL EMPLOYEES OF PROVIDERS OF TEMPORARY HOUSING ASSISTANCE WHO ARE
 AUTHORIZED TO ADMINISTER AN OPIOID ANTAGONIST SHALL:
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
  [ ] is old law to be omitted.
  LBD00670-03-4
 S. 1872--A  2
 
  (A) HAVE COMPLETED AN INITIAL TRAINING PROGRAM, WHICH  MAY  INCLUDE  A
 DEPARTMENT  OF  HEALTH  REGISTERED  OPIOID  OVERDOSE PREVENTION TRAINING
 PROGRAM;
  (B) COMPLETE A REFRESHER TRAINING PROGRAM AT LEAST EVERY TWO YEARS;
  (C)  CONTACT  THE  EMERGENCY  MEDICAL  SYSTEM DURING ANY RESPONSE TO A
 VICTIM OF SUSPECTED DRUG OVERDOSE AND ADVISE IF AN OPIOID ANTAGONIST  IS
 BEING USED;
  (D)  COMPLY  WITH  PROTOCOLS FOR RESPONSE TO VICTIMS OF SUSPECTED DRUG
 OVERDOSE; AND
  (E) REPORT ALL RESPONSES TO VICTIMS OF SUSPECTED DRUG OVERDOSE TO  THE
 DEPARTMENT OF HEALTH.
  3.  ALL  PROVIDERS  OF  TEMPORARY  HOUSING  ASSISTANCE SHALL DEVELOP A
 TRAINING  PLAN  IN  CONJUNCTION  WITH  A  REGISTERED  OPIOID  OVERDOSE
 PREVENTION PROGRAM IN THE APPLICABLE REGION REGARDING THE ADMINISTRATION
 OF  OPIOID  ANTAGONISTS TO ANY INDIVIDUAL RESIDING ON A PROVIDER'S PREM-
 ISES WHO IS AT RISK OF EXPERIENCING OR WITNESSING AN OPIOID OVERDOSE.
  4. FOR THE PURPOSES OF THIS SUBDIVISION, THE TERM "OPIOID  ANTAGONIST"
 SHALL  MEAN  A  FEDERAL FOOD AND DRUG ADMINISTRATION-APPROVED DRUG THAT,
 WHEN ADMINISTERED, NEGATES OR NEUTRALIZES IN WHOLE OR IN PART THE  PHAR-
 MACOLOGICAL  EFFECTS  OF  AN  OPIOID  IN THE BODY AND THAT IS LIMITED TO
 NALOXONE OR OTHER MEDICATIONS APPROVED BY THE DEPARTMENT OF  HEALTH  FOR
 THIS  PURPOSE AND "NALOXONE KIT" SHALL MEAN A PREFILLED NALOXONE SYRINGE
 OR NEEDLE-FREE INTRANASAL DRUG DELIVERY DEVICE.
  5. THE COMMISSIONER IS AUTHORIZED TO PROMULGATE RULES AND  REGULATIONS
 NECESSARY FOR THE IMPLEMENTATION OF THIS TITLE.
  ยง  2.  This  act shall take effect on the thirtieth day after it shall
 have become a law. Effective immediately, the addition, amendment and/or
 repeal of any rule or regulation necessary  for  the  implementation  of
 this  act  on its effective date are authorized to be made and completed
 on or before such effective date.